✦ LIBER ✦

Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer

✍ Scribed by Gonzalez-Angulo, A.M.; Blumenschein, G.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The PI3K/AKT/MTOR Signaling Pathway: The

✍ Huemer, Florian; Bartsch, Rupert; Gnant, Michael 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 355 KB

Targeting the PI3K/AKT/mTOR pathway in e

✍ Ciruelos Gil, Eva Maria 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Defining optimal combinations of PI3K/Ak

✍ Isani, S.S.; Rodriguez-Gabin, A.G.; Goldberg, G.L.; Horwitz, S.B.; McDaid, H.M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 147 KB

The PI3K/AKT/mTOR Signaling Pathway: Imp

✍ Eleni Andreopoulou 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

New in-capillary electrophoretic kinase

✍ Nehmé, Reine; Nehmé, Hala; Saurat, Thibault; de-Tauzia, Marie-Ludivine; Buron, F 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 743 KB

Targeting the PI3K/AKT/mTOR and Raf/MEK/

✍ Saini, Kamal S.; Loi, Sherene; de Azambuja, Evandro; Metzger-Filho, Otto; Saini, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 924 KB